1. Home
  2. CPIX vs ICCM Comparison

CPIX vs ICCM Comparison

Compare CPIX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ICCM
  • Stock Information
  • Founded
  • CPIX 1999
  • ICCM 2006
  • Country
  • CPIX United States
  • ICCM Israel
  • Employees
  • CPIX N/A
  • ICCM N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ICCM
  • Sector
  • CPIX Health Care
  • ICCM
  • Exchange
  • CPIX Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • CPIX 68.7M
  • ICCM 70.1M
  • IPO Year
  • CPIX 2009
  • ICCM N/A
  • Fundamental
  • Price
  • CPIX $4.70
  • ICCM $1.03
  • Analyst Decision
  • CPIX
  • ICCM Strong Buy
  • Analyst Count
  • CPIX 0
  • ICCM 1
  • Target Price
  • CPIX N/A
  • ICCM $2.50
  • AVG Volume (30 Days)
  • CPIX 21.7K
  • ICCM 199.2K
  • Earning Date
  • CPIX 05-06-2025
  • ICCM 05-27-2025
  • Dividend Yield
  • CPIX N/A
  • ICCM N/A
  • EPS Growth
  • CPIX N/A
  • ICCM N/A
  • EPS
  • CPIX N/A
  • ICCM N/A
  • Revenue
  • CPIX $41,083,299.00
  • ICCM $3,291,000.00
  • Revenue This Year
  • CPIX N/A
  • ICCM $97.02
  • Revenue Next Year
  • CPIX N/A
  • ICCM $212.86
  • P/E Ratio
  • CPIX N/A
  • ICCM N/A
  • Revenue Growth
  • CPIX 5.82
  • ICCM 1.92
  • 52 Week Low
  • CPIX $1.04
  • ICCM $0.48
  • 52 Week High
  • CPIX $7.25
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 52.45
  • ICCM 37.29
  • Support Level
  • CPIX $4.32
  • ICCM $1.00
  • Resistance Level
  • CPIX $4.86
  • ICCM $1.10
  • Average True Range (ATR)
  • CPIX 0.34
  • ICCM 0.08
  • MACD
  • CPIX -0.02
  • ICCM -0.01
  • Stochastic Oscillator
  • CPIX 36.89
  • ICCM 8.82

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: